Cargando…
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117797/ https://www.ncbi.nlm.nih.gov/pubmed/27657342 http://dx.doi.org/10.1038/bjc.2016.306 |
| _version_ | 1782468870857031680 |
|---|---|
| author | Chiorean, E Gabriela Von Hoff, Daniel D Tabernero, Josep El-Maraghi, Robert Wee Ma, Wen Reni, Michele Harris, Marion Whorf, Robert Liu, Helen Shiansong Li, Jack Manax, Victoria Romano, Alfredo Lu, Brian Goldstein, David |
| author_facet | Chiorean, E Gabriela Von Hoff, Daniel D Tabernero, Josep El-Maraghi, Robert Wee Ma, Wen Reni, Michele Harris, Marion Whorf, Robert Liu, Helen Shiansong Li, Jack Manax, Victoria Romano, Alfredo Lu, Brian Goldstein, David |
| author_sort | Chiorean, E Gabriela |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5117797 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-51177972016-12-17 Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer Chiorean, E Gabriela Von Hoff, Daniel D Tabernero, Josep El-Maraghi, Robert Wee Ma, Wen Reni, Michele Harris, Marion Whorf, Robert Liu, Helen Shiansong Li, Jack Manax, Victoria Romano, Alfredo Lu, Brian Goldstein, David Br J Cancer Corrigendum Nature Publishing Group 2016-10-25 2016-09-22 /pmc/articles/PMC5117797/ /pubmed/27657342 http://dx.doi.org/10.1038/bjc.2016.306 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| spellingShingle | Corrigendum Chiorean, E Gabriela Von Hoff, Daniel D Tabernero, Josep El-Maraghi, Robert Wee Ma, Wen Reni, Michele Harris, Marion Whorf, Robert Liu, Helen Shiansong Li, Jack Manax, Victoria Romano, Alfredo Lu, Brian Goldstein, David Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
| title | Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
| title_full | Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
| title_fullStr | Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
| title_full_unstemmed | Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
| title_short | Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
| title_sort | second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117797/ https://www.ncbi.nlm.nih.gov/pubmed/27657342 http://dx.doi.org/10.1038/bjc.2016.306 |
| work_keys_str_mv | AT chioreanegabriela secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT vonhoffdanield secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT tabernerojosep secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT elmaraghirobert secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT weemawen secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT renimichele secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT harrismarion secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT whorfrobert secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT liuhelen secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT shiansonglijack secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT manaxvictoria secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT romanoalfredo secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT lubrian secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer AT goldsteindavid secondlinetherapyafternabpaclitaxelplusgemcitabineoraftergemcitabineforpatientswithmetastaticpancreaticcancer |